Press release
Needle-Free Drug Delivery Devices Market Outlook, Demand, Drivers, Trends Report 2033
The Business Research Company recently released a comprehensive report on the Global Needle-Free Drug Delivery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.According to The Business Research Company's, The needle-free drug delivery devices market size has grown exponentially in recent years. It will grow from $14.99 billion in 2023 to $16.70 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for painless drug delivery methods, high geriatric population, emphasis on patient compliance and safety, regulatory support for needle-free technologies, and expanded pharmaceutical industry.
The needle-free drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $25.88 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing demand for painless medication administration, growing emphasis on patient-centric healthcare solutions, expanding applications in pediatric and geriatric populations, rising prevalence of chronic diseases necessitating frequent injections, technological advancements enhancing device efficiency and usability, expanding access to healthcare in emerging markets, and growing investments in research and development for innovative delivery systems. Major trends in the forecast period include increased adoption of wearable and connected devices, the emergence of novel microfluidic technologies, a growing focus on pediatric-friendly needle-free solutions, the integration of artificial intelligence and machine learning algorithms, and expanding applications in home healthcare settings.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report
Market Drivers and Trends:
The increasing prevalence of diabetes is expected to propel the growth of the needle-free drug delivery device market going forward. Diabetes presents as a persistent health issue marked by high blood sugar levels, stemming from inadequate insulin production or the body's ineffective utilization of insulin. Diabetes is on the rise due to sedentary lifestyles, unhealthy dietary habits, genetic predisposition, urbanization, and aging populations, compounded by limited access to healthcare and rising obesity rates worldwide. Needle-free drug delivery devices provide an alternative to conventional injections for insulin administration in diabetes care. It uses technologies such as jet injectors or transdermal patches that deliver insulin through the skin without needles, alleviating the discomfort and anxiety often linked with injections and enhancing comfort levels. For instance, in July 2021, according to the International Diabetes Federation, a Belgium-based organization, the projected number of individuals living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Therefore, the increasing prevalence of diabetes is driving the growth of the needle-free drug delivery device market.
Major companies operating in the needle-free drug delivery device market are focusing on advanced solutions, such as dual chamber inhalers, to enhance the efficacy and ease of administration and cater to the evolving needs of patients and healthcare providers. A dual-chamber inhaler is a device with two compartments that can hold different medications separately. This design allows for the combination of multiple drugs in a single inhaler, streamlining treatment and improving convenience for patients. For instance, in April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, a cutting-edge dry powder inhaler (DPI) designed to revolutionize patient-centered healthcare solutions. This dual-chamber inhaler boasts a dose counter, ensuring precise medication administration. Its all-plastic construction, devoid of any metal parts, makes it ideal for complex inhalation treatments, simplifying dosage and combining multiple drugs effectively. The advanced features include a bi-directional mouthpiece cover for convenience and hygiene, along with audible signals to indicate proper usage. The integrated dose counter aids in monitoring medication usage accurately, preventing dosage errors.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
Major Key Players of the Market:
Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG
Needle-Free Drug Delivery Devices Market 2024 Key Insights:
• The needle-free drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $25.88 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%.
• Diabetes As A Catalyst Is Driving Growth In The Needle-Free Drug Delivery Devices Market
• Advancements In Dual Chamber Inhalers Revolutionize The Needle-Free Drug Delivery Market
• North America was the largest region in the needle-free drug delivery devices market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15615&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Needle-Free Drug Delivery Devices Market Outlook, Demand, Drivers, Trends Report 2033 here
News-ID: 3701863 • Views: …
More Releases from The Business Research Company

Intratumoral Cancer Therapies Industry Report 2025-2034: Market Dynamics, Trends …
The Intratumoral Cancer Therapies Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Intratumoral Cancer Therapies Market Size and Its Estimated Growth Rate?
The market size for intratumoral cancer treatments has seen a significant increase in the past few years. It's predicted to…

Evolving Market Trends In The Insurance Advertising Industry: Insurance Advertis …
The Insurance Advertising Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Insurance Advertising Market Size and Its Estimated Growth Rate?
In recent times, the insurance advertising market has witnessed accelerated expansion. The market size is forecasted to rise from $12.77 billion in…

Rising Prevalence Of Chronic Diseases To Drive Market Growth: Key Factor Driving …
The Infusion Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Infusion Pump Market Size and Its Estimated Growth Rate?
The market size for infusion pumps has significantly expanded in the past few years. The expected growth is from $14.77 billion in…

Industrial Refrigeration Systems Industry Report 2025-2034: Market Dynamics, Tre …
The Industrial Refrigeration Systems Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Industrial Refrigeration Systems Market Size and Its Estimated Growth Rate?
In the past few years, the industrial refrigeration systems market has seen robust growth. The size is forecasted to increase…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…